Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men

類似資料

• Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
  著者:: McCoy, J., 等
  出版事項: (2020)
• Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients
  著者:: Cadegiani, F.A., 等
  出版事項: (2021)
• Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
  著者:: Cadegiani, Flavio A, 等
  出版事項: (2021)
• Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
  著者:: McCoy, John, 等
  出版事項: (2020)
• Androgen sensitivity gateway to COVID‐19 disease severity
  著者:: Wambier, Carlos Gustavo, 等
  出版事項: (2020)